2 - 4 November 2020
Delivered as a 100% Virtual Conference
in Greenwich Mean Time Zone (GMT)
Join Kayentis online at the
19th annual Clinical Trials Europe!
Global expert in electronic data capture for patients in clinical trials, Kayentis is specialized in eCOA solutions for phases IIB/III. We provide Pharma, Biotech and CROs with robust technology and smooth services to ensure patients and sites have the best experience, and sponsors get a high-quality & clean database.
VIRTUAL AGENDA AT A GLANCE
3 Days. 6 Streams. Countless Opportunities To Get Your Questions Answered.
Attendees will get access to all 6 conference streams, and with sessions made available on-demand for 30-days, you will have the opportunity to catch up on some of the bits you missed during the live event!
WHO'S SPEAKING AT CLINICAL TRIALS EUROPE?
Hear from thought-leaders and innovators from Regulatory Authorities, Patients, Pharma and Biotech Companies, CROs, Vendors and beyond...
KENNETH GETZ
Deputy Director and Professor
Tufts Center for the Study of Drug Development Tufts University, USA
*Free pass terms and conditions:
- Please note, all free pass registrants will be sent a short survey prior to the event to complete as part of their registration following their application. This will need to be completed in order for us to provide you with access to the virtual event.
- Free pass not applicable to supplier / vendor / CRO / technology / solution provider companies or consultants. Informa Connect Life Sciences will verify whether you are eligible for this free pass when your registration is processed. In the instances where you are found to be booked for a free pass and do not qualify, we will notify you and cancel your delegate booking, and assist you in connecting with our sponsorship and exhibitions team ( [email protected] / +44 (0) 20 337 73905 ) who will be able to discuss opportunities for participation with you.
Still unsure if you qualify? Contact [email protected] who will be able to inform you as to the correct pass option for you.